This application is a divisional application of U.S. Ser. No. 09/229,136, filed Jan. 12, 1999, now U.S. Pat. No. 6,127,186.
Entry |
---|
Raty et al. , “Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free. beta.-hCG levels.” Prenatal Diagnosis, (1999) 19/2 (122-27)-abstract.* |
Weinans et al., “Urinary hyperglycosylated hCG in first trimester screening for chromosomal abnormalities”, Prenatal Diagnosis, 2000, 20:976-978. |
Cole et al., “Combining β-core fragment and total oestriol measurements to test for Down syndrome pregnancies”, Prenatal Diagnosis, 1997, 17:12: 1125-1133. |
Cole et al., “Screening for Down syndrome using urine hCG free β-subunit in the second trimester of pregnancy”, Prenatal Diagnosis, 1997, 17:12: 1107-1111. |
Hallahan et al., “Comparison of Urinary free beta (hCG) and beta-core (hCG) in prenatal screening for chromosomal abnormalities”, Prenatal Diagnosis, 1998, 18: 893-900. |
Hsueh et al., “Human prorenin”, Hypertension, 1991, 17: 469. |
Derkx et al., “Immunoreactive renin, proprenin and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives”, J. Clin. Endocrinol. Metab., 1986, 63: 1008. |
Sealey, “Plasma renin activity and plasma prorenin assays”, Clin. Chem., 1991, 37:10(B), 1811-1819. |
Heusser et al., “Monoclonal antibodies to human renin: properties and applications”, Clin. Exper. Theory Practice, 1987: A9(8&9): 1259-1275. |
Zuo et al., “Characterization of a monoclonal antibody specific for human active renin”, Hypertension, 1992, 19:249-254. |
Simon et al., “Two-site direct immunoassay specific for active renin”, Clin. Chem., 1992, 38/10: 1959-1962. |
Rodbard et al., “Statistical analysis of radioimmunoassays and related procedures in medicine”, International Atomic Energy Agency, Vienna, 1994, vol. 1. |
Bogart et al., “Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities”, Prenatal Diagnosis, 1987, 7: 623-630. |
Brambati et al., “Serum PAPP-A free β-hCG are first-trimester screening markers for down syndrome”, Prenatal Diagnosis, 1994, 14: 1043-1047. |
Cole et al., “Comparison of 12 assays for detecting hCG and related molecules in urine samples from down syndrome pregnancies”, Prenatal Diagnosis, 1997, 17:7: 607-614. |
Crandall et al., “First-trimester maternal serum unconjugated oestriol and alpha-fetoprotein in fetal down's syndrome”, Prenatal Diagnosis, 1991 11: 377-380. |
Kratzer et al., “First-trimester aneuploidy screening using serum human chorionic gonadotropin (hCG), free ahCG, and progesterone”, Prenatal Diagnosis, 1991 11:751-765. |
Norton et al., “Maternal serum CA 125 for aneuploidy detection in early pregnancy”, Prenatal Diagnosis, 1992 12: 779-781. |